Navigation Links
New use of artificial lung device pioneered at University of Kentucky
Date:8/4/2011

Surgeons at the University of Kentucky on Aug. 3 announced that they were among the first to use artificial-lung technology to demonstrate the feasibility of a lung transplant, using a device invented by two university faculty members, Dr. Joseph Zwischenberger and Dr. Dongfang Wang.

"The device helps patients get oxygen into their blood by transporting blood to a gas exchanger that removes carbon dioxide and oxygenates the blood before returning it to the heart, bypassing the lungs of the patient," said Zwischenberger, chairman of the UK Department of Surgery. "It's meant for patients who are too sick to be maintained on a ventilator and is designed as temporary treatment for severe respiratory failure."

Normally, a patient is sedated while using an extracorporeal membrane oxygenation (ECMO). Consequently, the patient is bedridden, which causes the muscles to become increasingly weak. However, Zwischenberger's device, the bi-caval double lumen catheter, manufactured by Avalon Laboratories, is an advanced form of ECMO, also known as "ambulatory artificial lungs."

Zwischenberger's goal was to allow patients to do normal things, even exercise, while using the device.

That goal was achieved on April 8, when Dr. Charles Hoopes, director of the UK Heart and Lung Transplant Program and the Ventricular Assist Device Program, performed surgery on Ernie Gillispie, of Canada, Ky., to allow the use of this artificial lung and double lumen catheter.

With the assistance of the device, Gillispie proved himself to be a candidate for a lung transplant; without it he would not have been strong enough for the surgery, Zwischenberger said.

"This lung technology sets us up to be able to bridge patients to lung transplant, rather than their condition continuing to deteriorate while waiting for a transplant," Zwischenberger said. "Dr. Hoopes is an early adopter of this technique and we are now one of a very few places in the country that uses ambulatory ECMO as a bridge to transplant."

Hoopes says the machine proved that if Gillispie's lungs worked properly, he could live a normal life.

"If a patient cannot exercise after their breathing is 'replaced' with an artificial lung, then transplant will provide little clinical benefit," Hoopes said. "The limited number of donor organs can be used in patients who will most likely benefit. Artificial lung technology allows us to be certain that the patient potentially receiving the organ transplantation is physically well enough to undergo the surgery and recovery."

After only three days using the artificial lung, Gillispie underwent a successful double-lung transplant surgery on April 11.


'/>"/>

Contact: Julie Meador
Julie.Meador@uky.edu
859-323-2395
University of Kentucky
Source:Eurekalert

Related medicine news :

1. Related studies point to the illusion of the artificial
2. Artificial light quality affects herbivore preference for seedlings
3. Washington University surgeons successfully use artificial lung in toddler
4. 2-year results: Artificial disc a viable alternative to fusion for 2-level disc disease
5. Artificial tissue promotes skin growth in wounds
6. Latest Artificial Pancreas Trials Reduce Risk of Low Blood Sugar
7. University of Granada researchers make the first bioartificial organ in Spain
8. For back, neck pain, artificial disc replacement has cost, outcome advantages over fusion surgery
9. Biological joints could replace artificial joints soon
10. Artificial Turf Helps Football Players With Agility Drills
11. How football playing robots have the future of artificial intelligence at their feet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2017)... ... 2017 , ... Accreditation Commission for Health Care (ACHC) is ... (HCAOA). This agreement allows HCAOA members to receive special pricing on ACHC’s Home ... University (AU) educational resources that help prepare HCAOA members for ACHC Accreditation. , ...
(Date:4/28/2017)... ... ... Horizon Blue Cross Blue Shield of New Jersey (BCBSNJ) announced today that ... as “stable.” At the same time, the ratings agency cautioned that the company’s rating ... “capital adequacy” thresholds required for its strong rating. , “Horizon is committed to being ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... tubes . These lamps offer an instant energy-saving solution for F32T8 fluorescent lamps ... fixtures or disconnect ballasts. These 50,000 hour rated lamps utilize the existing electronic ...
(Date:4/28/2017)... ... ... The Texas Cord Blood Bank (TCBB), a program of nonprofit biomedical organization GenCure, ... at Renaissance in Edinburg for their outstanding efforts in collecting umbilical cord blood donations ... , “Women’s Hospital at Renaissance has been a collection partner for the TCBB since ...
(Date:4/28/2017)... Ca (PRWEB) , ... April 28, 2017 , ... Bill ... management industry in the coastal communities. After Tina Howe joined the team, the Bill ... happy employees, honest services at affordable rates, and giving back to the San Diego ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... financial results for the first quarter 2017 after the ... Company,s management team will host a corresponding conference call ... Investors interested in listening to the conference ... domestic callers or (703) 326-3030 for international callers, using ...
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
(Date:4/19/2017)... -- The Global Effective Microorganisms (EM) Market by ... covered and analysed the potential of Global Effective Microorganisms (EM) ... and growth factors. The report identifies and analyses the emerging ... global market. ... Tables and Figures, 6 Major Company Profiles, spread across 124 ...
Breaking Medicine Technology: